One-third of target group now vaccinated against monkeypox 10,440 monkeypox vaccinations have already been administered in the Netherlands in the last few weeks. That represents about one-third of the target group currently eligible to get the vaccine against monkeypox. Science Photo Library / ANP
RIVM formulates criteria for R&D of sustainable pharmaceuticals As part of an international research project, RIVM has formulated criteria for R&D of sustainable new pharmaceuticals. These GREENER criteria are an important first step to develop pharmaceuticals that do not impact the environment..
Number of monkeypox infections continues to rise More than 16,000 cases of monkeypox have now been confirmed worldwide, spread across 75 countries. Both the number of confirmed cases and the number of countries where the disease is present are continuing to rise
Monkeypox continues spreading Over the past few weeks, 288 people in the Netherlands have tested positive for monkeypox. The number of new daily infections seems to be slowly increasing. Science Photo Library / ANP
6 people in the Netherlands with monkeypox There are now 6 cases of monkeypox in humans in the Netherlands. Science Photo Library / ANP
First patient with monkeypox in the Netherlands This afternoon, a patient with monkeypox was confirmed in the Netherlands for the first time. RIVM researchers confirmed that the person has monkeypox with a PCR test. Science Photo Library / ANP
New criteria for amount of salt, sugar and saturated fat in foods The National Approach to Product Improvement (Nationale Aanpak Productverbetering, in Dutch NAPV) is set to start this year.
New: NEVO online 2021 RIVM published a new online edition of the Dutch food composition database (NEVO).
Estimated costs of foodborne infections 140 million euros lower in 2020 In 2020, the estimated costs of foodborne infections in the Netherlands were 140 million euros lower than in the preceding year. This corresponds to a 30% decrease. ANP
Zoonoses Report 2020 focuses on emerging zoonoses The COVID-19 pandemic and the outbreak of the West Nile Virus in 2020 show that so-called emerging zoonoses pose a risk to the Netherlands. ANP